Elligo Health Research Announces Acquisition of ePatientFinder Clinical Trial Exchange Technology Platform and Practice Network
Austin, Texas, May 24, 2018 (Business Wire) -
Elligo Health Research
, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients, has acquired
ePatientFinder’s
Clinical Trial Exchange technology platform and referring practice network, which is the largest of its kind. This acquisition will enhance Elligo’s trial matching process by incorporating ePatientFinder’s technology platform. Using this platform, Elligo will streamline patient identification and feasibility through automation using electronic health record (EHR) data within Elligo’s network of providers. “We believe this is an important strategic opportunity for Elligo to expand our technology and network growth capabilities,” said
John Potthoff
, PhD, CEO of Elligo Health Research. “ePatientFinder provides a technology platform and partnership ecosystem that will enable us to automate our EHR data analytics capabilities and expand our network of Research Ready™ sites to further benefit physicians, patients and sponsors.” Elligo implements its
Goes Direct™
approach to provide physicians with the personnel, procedures, technology and infrastructure to conduct trials in
Research Ready™
sites. This makes clinical trials more efficient and cost-effective, allowing patients to gain access to treatment options, enabling physicians to avoid the expenditure and effort of managing in-house infrastructure, and making it easier for sponsors to bring new therapies to market faster.
About Elligo
Elligo Health Research
offers the only platform that brings clinical research to physician practices, accelerating the development of new pharmaceutical, biotechnology and medical device products and therapies. Our Goes Direct™ approach uses state-of-the-art elliGO DIRECT™ technology to compliantly leverage current electronic health record data and applies a proprietary, prescreening process to match protocol-eligible patients for participation in clinical studies. It is our mission to support health care providers by providing personnel, procedures, technology and infrastructure for clinical research, enabling patients to participate in research while remaining under the care of their own trusted physician. Learn more at
elligodirect.com
.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
